Cumulative corticosteroid exposure in patients with GCA, with and without visual manifestations.
| Patients With Visual Manifestations, n = 47 | Patients Without Visual Manifestations, n = 157 | p | |
|---|---|---|---|
| One-yr cumulative corticosteroid dose | |||
| Mean (SD; g) | 5.4 (2.7) | 5.5 (2.5) | 0.93 |
| Median (IQR) | 5.4 (3.4–6.9) | 5.4 (3.7–7.1) | |
| 2-yr cumulative corticosteroid dose | |||
| Mean (SD; g) | 7.0 (3.7) | 7.3 (3.8) | 0.69 |
| Median (IQR) | 7.1 (4.0–9.3) | 7.2 (4.2–10.0) | |
| 5-yr cumulative corticosteroid dose | |||
| Mean (SD; g) | 9.9 (6.3) | 9.3 (6.3) | 0.63 |
| Median (IQR) | 8.3 (4.8–14.3) | 8.1 (4.3–12.7) |
GCA: giant cell arteritis; IQR: interquartile range.